S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
GE   10.99 (-0.99%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
ACB   2.62 (+7.82%)
F   9.01 (-0.11%)
PRI   135.35 (-0.24%)
NFLX   302.50 (-1.58%)
BAC   33.51 (-0.48%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
GE   10.99 (-0.99%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
ACB   2.62 (+7.82%)
F   9.01 (-0.11%)
PRI   135.35 (-0.24%)
NFLX   302.50 (-1.58%)
BAC   33.51 (-0.48%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
GE   10.99 (-0.99%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
ACB   2.62 (+7.82%)
F   9.01 (-0.11%)
PRI   135.35 (-0.24%)
NFLX   302.50 (-1.58%)
BAC   33.51 (-0.48%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
S&P 500   3,135.96 (-0.32%)
DOW   27,909.60 (-0.38%)
QQQ   204.07 (-0.45%)
AAPL   266.92 (-1.40%)
FB   201.34 (+0.14%)
MSFT   151.36 (-0.26%)
GOOGL   1,342.99 (+0.27%)
AMZN   1,749.51 (-0.12%)
CGC   21.29 (+14.16%)
NVDA   212.17 (+0.00%)
MU   46.45 (-3.09%)
BABA   198.74 (-1.56%)
GE   10.99 (-0.99%)
TSLA   339.53 (+1.08%)
T   38.04 (-0.42%)
AMD   38.93 (-1.77%)
ACB   2.62 (+7.82%)
F   9.01 (-0.11%)
PRI   135.35 (-0.24%)
NFLX   302.50 (-1.58%)
BAC   33.51 (-0.48%)
GILD   66.93 (-0.22%)
DIS   146.21 (-0.98%)
Log in

NYSE:MED - Medifast Stock Price, Forecast & News

$88.92
-1.65 (-1.82 %)
(As of 12/9/2019 04:00 PM ET)
Today's Range
$88.60
Now: $88.92
$91.51
50-Day Range
$72.95
MA: $93.23
$112.63
52-Week Range
$66.50
Now: $88.92
$159.41
Volume297,600 shs
Average Volume309,934 shs
Market Capitalization$1.03 billion
P/E Ratio19.25
Dividend Yield3.31%
Beta0.65
Medifast, Inc, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products. It offers bars, bites, pretzels, puffs, oatmeal and cereal crunch products, drinks, hearty choices, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by OPTAVIA, Flavors of Home, and Essential 1 brands. Read More…

Industry, Sector and Symbol

Industry Miscellaneous food preparations & kindred products
Sub-IndustryPersonal Products
SectorConsumer Staples
CUSIP58470H10
Phone410-581-8042

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$501 million
Cash Flow$4.99 per share
Book Value$9.12 per share

Profitability

Net Income$55.79 million

Miscellaneous

Employees420
Market Cap$1.03 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive MED News and Ratings via Email

Sign-up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter.


Medifast (NYSE:MED) Frequently Asked Questions

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, December 5th. Investors of record on Friday, December 27th will be paid a dividend of $1.13 per share on Thursday, February 6th. This represents a $4.52 dividend on an annualized basis and a dividend yield of 5.08%. The ex-dividend date of this dividend is Thursday, December 26th. This is a positive change from Medifast's previous quarterly dividend of $0.75. View Medifast's Dividend History.

How were Medifast's earnings last quarter?

Medifast Inc (NYSE:MED) released its earnings results on Thursday, November, 7th. The specialty retailer reported $1.32 earnings per share for the quarter, missing the consensus estimate of $1.33 by $0.01. The specialty retailer earned $190.10 million during the quarter, compared to analysts' expectations of $194.70 million. Medifast had a return on equity of 62.93% and a net margin of 10.70%. The business's revenue for the quarter was up 36.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.14 earnings per share. View Medifast's Earnings History.

When is Medifast's next earnings date?

Medifast is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Medifast.

What guidance has Medifast issued on next quarter's earnings?

Medifast issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $5.80-5.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $6.83. The company issued revenue guidance of $$700-710 million, compared to the consensus revenue estimate of $$750.45 million.

What price target have analysts set for MED?

4 Wall Street analysts have issued 1-year price objectives for Medifast's shares. Their forecasts range from $74.00 to $216.00. On average, they expect Medifast's stock price to reach $140.00 in the next year. This suggests a possible upside of 57.4% from the stock's current price. View Analyst Price Targets for Medifast.

What is the consensus analysts' recommendation for Medifast?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medifast.

Has Medifast been receiving favorable news coverage?

News stories about MED stock have trended somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medifast earned a media sentiment score of 1.3 on InfoTrie's scale. They also gave news stories about the specialty retailer a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Medifast.

Are investors shorting Medifast?

Medifast saw a increase in short interest in November. As of November 15th, there was short interest totalling 3,780,000 shares, an increase of 6.5% from the October 31st total of 3,550,000 shares. Based on an average trading volume of 366,600 shares, the days-to-cover ratio is currently 10.3 days. Approximately 33.1% of the company's stock are short sold. View Medifast's Current Options Chain.

Who are some of Medifast's key competitors?

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Mastercard (MA), Paypal (PYPL), Adobe (ADBE), Boeing (BA), Home Depot (HD), UnitedHealth Group (UNH) and Visa (V).

Who are Medifast's key executives?

Medifast's management team includes the folowing people:
  • Mr. Daniel R. Chard, CEO & Director (Age 54)
  • Mr. Timothy G. Robinson CPA, CPA, Chief Financial Officer (Age 57)
  • Mr. William Baker IV, Exec. VP of Information Technology (Age 47)
  • Mr. Nicholas Johnson, Exec. VP of Coach Success Market Pres of OPTAVIA USA (Age 39)
  • Mr. Jason L. Groves, Exec. VP, Gen. Counsel & Corp. Sec. (Age 48)

Who are Medifast's major shareholders?

Medifast's stock is owned by many different of retail and institutional investors. Top institutional investors include Engaged Capital LLC (4.41%), Pictet Asset Management Ltd. (3.39%), Rice Hall James & Associates LLC (2.89%), State Street Corp (2.90%), Man Group plc (1.27%) and Squarepoint Ops LLC (0.79%). Company insiders that own Medifast stock include Carl E Sassano, Charles P Connolly, Constance J Hallquist, Daniel R Chard, Michael A Hoer, Michael C Macdonald and Scott Schlackman. View Institutional Ownership Trends for Medifast.

Which major investors are selling Medifast stock?

MED stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Strs Ohio, California Public Employees Retirement System, State of Tennessee Treasury Department, Virtu Financial LLC, Great West Life Assurance Co. Can, Eqis Capital Management Inc. and Robeco Institutional Asset Management B.V.. Company insiders that have sold Medifast company stock in the last year include Carl E Sassano and Scott Schlackman. View Insider Buying and Selling for Medifast.

Which major investors are buying Medifast stock?

MED stock was purchased by a variety of institutional investors in the last quarter, including Engaged Capital LLC, Rice Hall James & Associates LLC, Pictet Asset Management Ltd., Man Group plc, Squarepoint Ops LLC, Voloridge Investment Management LLC, Garnet Equity Capital Holdings Inc. and First Trust Advisors LP. Company insiders that have bought Medifast stock in the last two years include Daniel R Chard and Michael A Hoer. View Insider Buying and Selling for Medifast.

How do I buy shares of Medifast?

Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $88.92.

How big of a company is Medifast?

Medifast has a market capitalization of $1.03 billion and generates $501 million in revenue each year. The specialty retailer earns $55.79 million in net income (profit) each year or $4.62 on an earnings per share basis. Medifast employs 420 workers across the globe.View Additional Information About Medifast.

What is Medifast's official website?

The official website for Medifast is http://www.medifast1.com/.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]


MarketBeat Community Rating for Medifast (NYSE MED)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  324 (Vote Outperform)
Underperform Votes:  333 (Vote Underperform)
Total Votes:  657
MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe MED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Featured Article: Retained Earnings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel